40 results on '"Yogo N"'
Search Results
2. P2.01-91 Exosomal Analysis of ALK Rearrangements by Spin Column with Porous Glass Filter
- Author
-
Hatta, T., primary, Hase, T., additional, Ozawa, N., additional, Yogo, N., additional, Yukawa, H., additional, Tanaka, H., additional, Onoshima, D., additional, Sato, M., additional, Hori, M., additional, Baba, Y., additional, and Hasegawa, Y., additional
- Published
- 2019
- Full Text
- View/download PDF
3. TMS-EEG and TMS-EMG to assess the pharmacodynamic profile of a novel potassium channel opener (XEN1101) on human cortical excitability
- Author
-
Premoli, I., primary, Beatch, G., additional, Rossini, P., additional, Abela, E., additional, Posadas, K., additional, Green, L., additional, Yogo, N., additional, Goldberg, P., additional, and Richardson, M., additional
- Published
- 2019
- Full Text
- View/download PDF
4. TMS-induced oscillations to evaluate pharmacodynamics properties of a newly developed anti-epileptic drug (XEN1101)
- Author
-
Rossini, P., primary, Premoli, I., additional, Beatch, G., additional, Abela, E., additional, Posadas, K., additional, Green, L., additional, Yogo, N., additional, and Richardson, M., additional
- Published
- 2019
- Full Text
- View/download PDF
5. Development of the immuno-wall device for rapid detection of ALK and ROS1 fusions in lung cancer
- Author
-
Yogo, N., primary, Hase, T., additional, Kasama, T., additional, Hatta, T., additional, OZAWA, N., additional, Sato, M., additional, Kaji, N., additional, Tokeshi, M., additional, Baba, Y., additional, and Hasegawa, Y., additional
- Published
- 2018
- Full Text
- View/download PDF
6. P3.01-34 Short Hydration Regimen with a Modified Dose of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy
- Author
-
Hase, T., primary, Miyazaki, M., additional, Ichikawa, K., additional, Yogo, N., additional, Ozawa, N., additional, Ando, M., additional, Morise, M., additional, Sato, M., additional, Kondo, M., additional, Yamada, K., additional, and Hasegawa, Y., additional
- Published
- 2018
- Full Text
- View/download PDF
7. Development of the immuno-wall device for rapid, low-cost detection of EGFR mutations in tumor samples from patients with lung cancer
- Author
-
Yogo, N., primary, Hase, T., additional, Kasama, T., additional, Ozawa, N., additional, Sato, M., additional, Kaji, N., additional, Tokeshi, M., additional, Baba, Y., additional, and Hasegawa, Y., additional
- Published
- 2017
- Full Text
- View/download PDF
8. P3.03-013 Identification of Proteosomal Catalytic Subunit PSMA6 as a Therapeutic Target for Lung Cancer through a Pooled shRNA Screen
- Author
-
Sato, M., primary, Kakumu, T., additional, Goto, D., additional, Kato, T., additional, Yogo, N., additional, Hase, T., additional, Morise, M., additional, Fukui, T., additional, Yokoi, K., additional, Sekido, Y., additional, Girard, L., additional, Minna, J., additional, Byers, L., additional, Heymach, J., additional, Coombes, K., additional, Kondo, M., additional, and Hasegawa, Y., additional
- Published
- 2017
- Full Text
- View/download PDF
9. 394P - Development of the immuno-wall device for rapid detection of ALK and ROS1 fusions in lung cancer
- Author
-
Yogo, N., Hase, T., Kasama, T., Hatta, T., OZAWA, N., Sato, M., Kaji, N., Tokeshi, M., Baba, Y., and Hasegawa, Y.
- Published
- 2018
- Full Text
- View/download PDF
10. 393P - Development of the immuno-wall device for rapid, low-cost detection of EGFR mutations in tumor samples from patients with lung cancer
- Author
-
Yogo, N., Hase, T., Kasama, T., Ozawa, N., Sato, M., Kaji, N., Tokeshi, M., Baba, Y., and Hasegawa, Y.
- Published
- 2017
- Full Text
- View/download PDF
11. Sepedonium intra-abdominal infection: a case report and review of an emerging fungal infection
- Author
-
Yogo, N., primary, Shapiro, L., additional, and Erlandson, K. M., additional
- Published
- 2014
- Full Text
- View/download PDF
12. Cardiopulmonary limited ultrasound examination for "quick-look" bedside application.
- Author
-
Kimura BJ, Yogo N, O'Connell CW, Phan JN, Showalter BK, Wolfson T, Kimura, Bruce J, Yogo, Norihiro, O'Connell, Charles W, Phan, James N, Showalter, Brian K, and Wolfson, Tanya
- Abstract
Although taking a "quick look" at the heart using a small ultrasound device is now feasible, a formal ultrasound imaging protocol to augment the bedside physical examination has not been developed. Therefore, we sought to evaluate the diagnostic accuracy and prognostic value of a cardiopulmonary limited ultrasound examination (CLUE) using 4 simplified diagnostic criteria that would screen for left ventricular dysfunction (LV), left atrial (LA) enlargement, inferior vena cava plethora (IVC+), and ultrasound lung comet-tail artifacts (ULC+) in patients referred for echocardiography. The CLUE was tested by interpretation of only the parasternal LV long-axis, subcostal IVC, and 2 lung apical views in each of 1,016 consecutive echocardiograms performed with apical lung imaging. For inpatients, univariate and multivariate logistic regression analyses were performed to assess the relations between mortality, CLUE findings, age, and gender. In this echocardiographic referral series, 78% (n = 792) were inpatient and 22% (n = 224) were outpatient. The CLUE criteria demonstrated a sensitivity, specificity, and accuracy for a LV ejection fraction of ≤40% of 69%, 91%, and 89% and for LA enlargement of 75%, 72%, and 73%, respectively. CLUE findings of LV dysfunction, LA enlargement, IVC+, and ULC+ were seen in 16%, 53%, 34%, and 28% of inpatients. The best multivariate logistic model contained 3 predictors of in-hospital mortality: ULC+, IVC+ and male gender, with adjusted odds ratios (95% confidence intervals) of 3.5 (1.4 to 8.8), 5.8 (2.1 to 16.4), and 2.3 (0.9 to 5.8), respectively. In conclusion, a CLUE consisting of 4 quick-look "signs" has reasonable diagnostic accuracy for bedside use and contains prognostic information. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
13. P2-007 - CBDCA + Pemetrexed + Bevacizumab and its Maintenance Chemotherapy as a Second Line in a Case of Sole Breast Metastasis from Lung Adenocarcinoma after Complete Response by Gefitinib as a First-Line Chemotherapy
- Author
-
Sato, K., Yoshihara, M., Takeyama, Y., Yogo, N., Ohdate, M., Fukui, Y., Gonda, H., and Suzuki, R.
- Published
- 2012
- Full Text
- View/download PDF
14. Change of chemical and biological water environment at a newly constructed reservoir
- Author
-
Inoue, S., Yogo, N., Ioriya, T., and Haga, M.
- Subjects
- *
WATER quality monitoring - Abstract
The changes of chemical and biological water environment of Lake Sapporo were investigated for over eight years from the beginning of water storage, and this is the first detailed report concerning the reservoirs situated in sub-frigid zones in Japan. The pollution load flowing into this reservoir is only nature-derived. At Lake Sapporo, the large inflow of water from the melting snow in spring supplies the middle and bottom layers with oxygen, and replaces water in the reservoir with new water. Under these circumstances, after effects of the initial deterioration were detected during two years in water quality, three years in phytoplankton composition and four years in zooplankton composition. [ABSTRACT FROM AUTHOR]
- Published
- 1997
15. Post-extubation dysphagia in pediatric trauma patients: a single-center case-series study.
- Author
-
Yogo N, Abe T, Kano K, Muto Y, Kiyonaga S, and Hirai K
- Subjects
- Humans, Child, Airway Extubation adverse effects, Length of Stay, Intubation, Intratracheal adverse effects, Retrospective Studies, Deglutition Disorders etiology, Deglutition Disorders therapy, Deglutition Disorders epidemiology, Craniocerebral Trauma complications
- Abstract
We aimed to investigate whether ventilator support time influences the occurrence of dysphagia in pediatric trauma patients. This case-series study was conducted in a single pediatric emergency and critical care center from April 2012 to March 2022. Trauma patients aged < 16 years who underwent tracheal intubation were divided into two groups based on the occurrence of dysphagia within 72 h after extubation, and their data were analyzed. Tracheal intubation was performed in 75 pediatric trauma patients, and 53 of them were included in the analysis. A total of 22 patients had post-extubation dysphagia and head trauma. The dysphagia group tended to have more severe head injuries (Abbreviated Injury Scale (AIS) 4 [4-5] vs. 4 [0-4]; p < 0.05), a longer ventilator support time (7 days [4-11] vs. 1 day [1-2.5]; p < 0.05), and a longer length of hospital stay (27 days [18.0-40.3] vs. 11 days [10.0-21.0]; p < 0.05). Severe head trauma and a long duration of tracheal intubation may be risk factors for dysphagia in pediatric trauma patients. Therefore, early recognition of these risk factors could assist in treatment planning for speech-language pathologist intervention and nutritional routes of administration., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
16. Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer.
- Author
-
Hatta T, Hase T, Hara T, Kimura T, Kojima E, Abe T, Horio Y, Goto Y, Ozawa N, Yogo N, Shibata H, Shimokata T, Oguri T, Yamamoto M, Yanagisawa K, Ando M, Ando Y, Kondo M, Ishii M, and Hasegawa Y
- Subjects
- Humans, Aged, Carboplatin, Creatinine therapeutic use, Treatment Outcome, Glomerular Filtration Rate, Lung Neoplasms drug therapy, Antineoplastic Agents therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy
- Abstract
Background: The Cockcroft-Gault formula is commonly used as a substitute for glomerular filtration rate (GFR) in Calvert's formula for carboplatin dosing, where adjusting serum creatinine measured using the enzymatic method with 0.2 mg/dL has been suggested in Japan. However, the effects of these adjustments on efficacy in patients with non-small-cell lung cancer remain unknown., Methods: We conducted a post hoc analysis of the PREDICT1 study (CJLSG1201), a multicenter prospective observational trial of carboplatin-pemetrexed. Glomerular filtration rate values in Calvert's formula were back-calculated from the administered dosages of carboplatin and the reported value of the target area under the curve. We estimated the serum creatinine adjustments and divided the patients into crude and adjusted groups., Results: Patients in the crude group (N = 169) demonstrated similar efficacy to those in the adjusted group (N = 104) in progression-free survival (PFS) and overall survival (OS) (hazard ratio [HR], 1.02; 95% confidence interval [CI], 0.76-1.35; p = 0.916 vs. HR, 0.87; 95% CI, 0.65-1.17; p = 0.363), with higher grade 3-4 hematologic toxicity. Among patients aged ≥75 years, the crude group (N = 47) showed superior efficacy compared with the adjusted group (N = 17) in PFS and OS (HR, 0.37; 95% CI, 0.20-0.69; p = 0.002 vs. HR, 0.43; 95% CI, 0.23-0.82; p = 0.010)., Conclusions: Serum creatinine adjustment may be associated with similar efficacy compared to the crude serum creatinine value. In older patients, the adjustment should be cautiously applied owing to the potential for reduced efficacy., (© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
17. High-performance glass filters for capturing and culturing circulating tumor cells and cancer-associated fibroblasts.
- Author
-
Tanaka H, Iwata D, Shibata Y, Hase T, Onoshima D, Yogo N, Shibata H, Sato M, Ishikawa K, Nagasawa I, Hasegawa Y, Ishii M, Baba Y, and Hori M
- Subjects
- Humans, Cell Line, Tumor, Neoplastic Cells, Circulating pathology, Cancer-Associated Fibroblasts pathology, Lung Neoplasms diagnosis, Lung Neoplasms pathology
- Abstract
Various liquid biopsy methods have been developed for the non-invasive and early detection of diseases. In particular, the detection of circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs) in blood has been receiving a great deal of attention. We have been developing systems and materials to facilitate such liquid biopsies. In this study, we further developed glass filters (with various patterns of holes, pitches, and non-adhesive coating) that can capture CTCs, but not white blood cells. We optimized the glass filters to capture CTCs, and demonstrated that they could be used to detect CTCs from lung cancer patients. We also used the optimized glass filters for detecting CAFs. Additionally, we further developed a system for visualizing the captured cells on the glass filters. Finally, we demonstrated that we could directly culture the captured cells on the glass filters. Based on these results, our high-performance glass filters appear to be useful for capturing and culturing CTCs and CAFs for further examinations., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
18. Oral to nasal endotracheal tube exchange using tracheal tube guide and video laryngoscope in a pediatric patient with facial burns: a case report.
- Author
-
Yogo N, Sasaki T, Kozumi M, Kinoshita Y, Muto Y, Hirai K, and Yoshino Y
- Abstract
Background: Airway management in children with severe burns is difficult because of airway edema and prolonged duration of ventilatory management. There is insufficient evidence to suggest that tracheostomy is beneficial for children., Case Presentation: A male child aged 1 year and 4 months was injured when he accidentally fell into a bathtub filled with boiling water. Furthermore, 85% of the burnt area, including the face and neck, consisted of second-degree burns; hence, oral tracheal intubation and resuscitative infusion were required. In this case, the patient was safely switched from oral to nasotracheal intubation using a tracheal tube guide and video laryngoscope, without the use of a bronchoscope, and ventilatory management could be continued for 2 weeks., Conclusion: Oral to nasal endotracheal tube exchange using a tracheal tube guide and video laryngoscope may be useful not only for pediatric burn patients but also for adult patients who need to be safely switched from oral to nasotracheal intubation., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
19. Child requiring tracheostomy for removal of an airway foreign body at the tracheal bifurcation.
- Author
-
Yogo N, Mizutari S, Honda K, and Asai H
- Subjects
- Bronchoscopy, Child, Humans, Trachea diagnostic imaging, Trachea surgery, Tracheostomy adverse effects, Airway Obstruction complications, Airway Obstruction surgery, Foreign Bodies complications, Foreign Bodies diagnostic imaging, Foreign Bodies surgery
- Abstract
Airway foreign bodies are typically removed orally using a rigid bronchoscope. We present a rare case of a foreign body at the tracheal bifurcation that required removal via tracheostomy. A child turned pale while eating nuts and was suspected to have choked on a foreign body. CT revealed a foreign body at the tracheal bifurcation. As his respiratory condition was unstable, tracheal intubation and removal were attempted using a rigid bronchoscope. Tracheal obstruction during oral removal resulted in respiratory failure and bradycardia. Following emergency tracheostomy, the foreign body was removed via the tracheal stoma after his respiratory condition stabilised. The patient was discharged 21 days later without neurological sequelae. To avoid hypoxaemia during airway foreign body removal, as in this case, assessing the size of the upper airway and foreign body is necessary. Tracheostomy and foreign body removal through the tracheal opening should be considered proactively., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
20. Paediatric progressive primary tuberculosis.
- Author
-
Yogo N, Furukawa C, and Hayano S
- Abstract
A previously healthy 13-year-old Japanese girl with a BCG vaccination history and no tuberculosis (TB) exposure history presented to the hospital with mild dyspnea for 1 month and fever for 5 days. Computed tomography showed consolidation with a pleural effusion, obstructed left main bronchus with an air bronchogram, and traction bronchiectasis of the left upper lobe (Fig. 1A, B). No improvement was observed with ampicillin. Computed tomography on day 23 showed a new granular shadow in the right upper lobe (Fig. 1C). Despite a negative interferon-gamma release assay (IGRA) result, the sputum on day 55 was positive for acid-fast bacilli on a ZiehlNeelsen stain and Mycobacterium tuberculosis on polymerase chain reaction. A fourdrug antituberculous regimen was initiated and she recovered rapidly. TB exposure history, positive tuberculin skin test or IGRA, and typical imaging findings are the triad for primary TB diagnosis (Perez-Velez and Marais, 2012; Lewinsohn et al., 2017; Ahmed et al., 2020). In pediatric primary TB, consolidation may be present and can be misdiagnosed as bacterial pneumonia; however, massive consolidation is rare (GriffithRichards et al., 2007). Primary pulmonary TB should be considered in children with lung consolidation that is unresponsive to antibiotics, despite negative IGRA and TB exposure history., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
21. Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
- Author
-
Yamamoto T, Ito T, Hase T, Ishigami M, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Shibata H, Hatta T, Yogo N, Yasuda S, Toyoda H, Abe T, Kawashima H, Hashimoto N, and Fujishiro M
- Subjects
- Aged, Carcinoma, Non-Small-Cell Lung mortality, Chemical and Drug Induced Liver Injury mortality, Drug Administration Schedule, Female, Humans, Immune Checkpoint Inhibitors therapeutic use, Lung Neoplasms mortality, Male, Middle Aged, Prognosis, Retrospective Studies, Survival Analysis, Treatment Outcome, Carcinoma, Non-Small-Cell Lung drug therapy, Chemical and Drug Induced Liver Injury epidemiology, Immune Checkpoint Inhibitors adverse effects, Lung Neoplasms drug therapy
- Abstract
It remains unclear whether severe liver immune-related adverse events (liver-irAEs) can affect the prognosis in nonsmall cell lung carcinoma (NSCLC) patients. Of the 365 NSCLC patients treated with immune checkpoint inhibitors (ICIs), 19 suffered from severe liver-irAEs (grade ≥3). The median time-to-onset of liver-irAEs was 53 days postinjection of the first ICI. The progression-free survival and overall survival of the liver-irAEs group (median 69 and 262 days, respectively) were significantly worse than the nonliver-irAEs group (128 and 722 days; P = 0.010 and P = 0.007; respectively). In conclusion, liver-irAEs were associated with poor prognosis in NSCLC patients.
- Published
- 2022
- Full Text
- View/download PDF
22. Simplified Clinical Decision Rule Using Clinically Important Events for Risk Prediction in Pediatric Head Injury: A Retrospective Cohort Study.
- Author
-
Yogo N, Toida C, Muguruma T, Gakumazawa M, Shinohara M, and Takeuchi I
- Abstract
Computed tomography (CT) scans are useful for confirming head injury diagnoses. However, there is no standard clinical decision rule (CDR) for determining the need for CT scanning in pediatric patients with head injuries. We developed a CDR and conducted a retrospective cohort study to evaluate its diagnostic accuracy in identifying children with clinically important traumatic brain injury (ciTBI). We selected predictors based on three existing CDRs: CATCH, CHALICE, and PECARN. Of the 2569 eligible patients, 645 (439 (68%) boys, median age: five years) were included in this study. In total, 59 (9%) patients showed ciTBI, and 129 (20%) were admitted to hospital. The novel CDR comprised six predictors of abnormal CT findings. It had a sensitivity of 79.5% (95% confidence interval (CI): 65.5-89.0%) and a specificity of 50.9% (95% CI: 48.9-52.3%). The area under the receiver-operating characteristic curve (0.72, 95% CI: 0.67-0.77) was non-inferior to those of CATCH, CHALICE, and PECARN (0.71, 95% CI: 0.66-0.77; 0.67, 95% CI: 0.61-0.74; and 0.69, 95% CI: 0.64-0.73, respectively; p = 0.57). The novel CDR was statistically noninferior in diagnostic accuracy compared to the three existing CDRs. Further development and validation studies are needed before clinical application.
- Published
- 2021
- Full Text
- View/download PDF
23. Methaemoglobinaemia due to food protein-induced enterocolitis syndrome.
- Author
-
Yogo N and Fujito S
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2021
- Full Text
- View/download PDF
24. Point prevalence survey to evaluate the seropositivity for coronavirus disease 2019 (COVID-19) among high-risk healthcare workers.
- Author
-
Yogo N, Greenwood KL, Thompson L, Wells PJ, Munday S, Smith TC, Smith B, and Bakhtar OR
- Subjects
- Health Personnel, Humans, Prevalence, SARS-CoV-2, Surveys and Questionnaires, COVID-19
- Abstract
Among 1,770 healthcare workers serving in high-risk care areas for coronavirus disease 2019 (COVID-19), 39 (2.2%) were seropositive. Exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in the community was associated with being seropositive. Job or unit type and percentage of time working with COVID-19 patients were not associated with positive antibody tests.
- Published
- 2021
- Full Text
- View/download PDF
25. Comparing incidences of infusion site reactions between brand-name and generic vinorelbine in patients with non-small cell lung cancer.
- Author
-
Ozawa N, Hase T, Hatta T, Sagara A, Ichikawa K, Miyazaki M, Yogo N, Ando M, Hashimoto N, Yamada K, and Hasegawa Y
- Subjects
- Drugs, Generic adverse effects, Humans, Incidence, Injection Site Reaction, Retrospective Studies, Vinorelbine adverse effects, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung epidemiology, Lung Neoplasms drug therapy, Lung Neoplasms epidemiology
- Abstract
Aim: This study aimed to compare the incidence of infusion site reactions (ISRs) induced by intravenous administration of brand-name and generic vinorelbine (VNR) for treating non-small cell lung cancer., Method: This single-centre retrospective cohort study was conducted by medical chart review of VNR infusions. ISRs were defined as symptoms around the infusion site, including pain, redness and swelling. ISRs requiring treatment were defined as ISRs requiring treatments including steroid ointments, vein repuncture and local steroid injections., Results: In all, 1973 VNR infusions were administered to 340 patients (brand-name 141 patients, generic 199 patients). ISRs and ISRs requiring treatment were observed in 161 and 100 patients, respectively. The ISR incidence per patient and per injection was significantly higher in generic VNR-treated patients than in brand-name VNR-treated patients (53.3% vs 39.0%, P = 0.0112 and 15.0% vs 9.9%, P = 0.0008, respectively). The frequency of ISRs requiring treatment was also significantly higher in the generic group (per patient 36.7% vs 19.2%, P = 0.0005; per injection 11.3% vs 5.5%, P < 0.0001). Multivariate analysis revealed that generic VNR was significantly associated with an increased risk of ISRs (per patient adjusted odds ratio [AOR] 1.775, P = 0.0155; per injection AOR 1.672, P = 0.004) and ISRs requiring treatment (per patient AOR 2.422, P = 0.0012; per injection AOR 2.286, P = 0.001)., Conclusion: Intravenous infusion of generic VNR was associated with an increased risk of ISRs. Further research is needed to elucidate the mechanism underlying the increased incidence of ISRs with generic VNR., (© 2020 The British Pharmacological Society.)
- Published
- 2021
- Full Text
- View/download PDF
26. Development of an immuno-wall device for the rapid and sensitive detection of EGFR mutations in tumor tissues resected from lung cancer patients.
- Author
-
Yogo N, Hase T, Kasama T, Nishiyama K, Ozawa N, Hatta T, Shibata H, Sato M, Komeda K, Kawabe N, Matsuoka K, Chen-Yoshikawa TF, Kaji N, Tokeshi M, Baba Y, and Hasegawa Y
- Subjects
- Calibration, Cell Line, Tumor, ErbB Receptors genetics, ErbB Receptors immunology, Fluorescence, Genotype, Humans, Immunoassay, DNA Mutational Analysis instrumentation, Lung Neoplasms genetics, Mutation genetics
- Abstract
Detecting molecular targets in specimens from patients with lung cancer is essential for targeted therapy. Recently, we developed a highly sensitive, rapid-detection device (an immuno-wall device) that utilizes photoreactive polyvinyl alcohol immobilized with antibodies against a target protein via a streptavidin-biotin interaction. To evaluate its performance, we assayed epidermal growth factor receptor (EGFR) mutations, such as E746_A750 deletion in exon 19 or L858R substitution in exon 21, both of which are common in non-small cell lung cancer and important predictors of the treatment efficacy of EGFR tyrosine kinase inhibitors. The results showed that in 20-min assays, the devices detected as few as 1% (E746_A750 deletion) and 0.1% (L858R substitution) of mutant cells. Subsequent evaluation of detection of the mutations in surgically resected lung cancer specimens from patients with or without EGFR mutations and previously diagnosed using commercially available, clinically approved genotyping assays revealed diagnostic sensitivities of the immuno-wall device for E746_A750 deletion and L858R substitution of 85.7% and 87.5%, respectively, with specificities of 100% for both mutations. These results suggest that the immuno-wall device represents a good candidate next-generation diagnostic tool, especially for screening of EGFR mutations., Competing Interests: T. Hase received personal fees from Chugai Pharmaceutical Co. Ltd., Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb Co., and Boehringer Ingelheim, and research funding from Boehringer Ingelheim, and Taiho Pharmaceutical Co. Ltd., outside the submitted work. Y. Hasegawa received grants from Boehringer Ingelheim, AstraZeneca, Eli Lilly Japan K.K., Ono Pharmaceutical Co. Ltd., Bristol-Myers Squibb Co., Taiho Pharmaceutical Co. Ltd., Novartis Pharma K. K., and Chugai Pharmaceutical Co. Ltd., and personal fee from Boehringer Ingelheim, MSD K.K., AstraZeneca, Pfizer Inc., and Chugai Pharmaceutical Co. Ltd, outside the submitted work. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2020
- Full Text
- View/download PDF
27. Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.
- Author
-
Hase T, Miyazaki M, Ichikawa K, Yogo N, Ozawa N, Hatta T, Ando M, Sato M, Kondo M, Yamada K, and Hasegawa Y
- Subjects
- Adult, Aged, Antiemetics therapeutic use, Antineoplastic Agents administration & dosage, Antineoplastic Combined Chemotherapy Protocols adverse effects, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cisplatin administration & dosage, Creatinine analysis, Dietary Supplements, Female, Humans, Kidney Diseases chemically induced, Kidney Function Tests, Magnesium administration & dosage, Magnesium blood, Male, Middle Aged, Palonosetron therapeutic use, Prospective Studies, Protective Agents therapeutic use, Renal Insufficiency etiology, Antineoplastic Agents adverse effects, Cisplatin adverse effects, Kidney Diseases prevention & control, Lung Neoplasms drug therapy, Magnesium therapeutic use
- Abstract
Background: Intravenous administration of magnesium with a short hydration regimen is recommended for patients receiving high-dose cisplatin to protect against cisplatin-induced nephrotoxicity. However, the optimal dose of magnesium supplementation has not been clarified. The aim of this trial was to investigate the safety and efficacy of a short hydration regimen with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy., Methods: The key eligibility criteria included cytologically or histologically diagnosed lung cancer, candidacy for cisplatin-based (≥ 60 mg/m
2 ) chemotherapy or chemoradiotherapy, no prior chemotherapy, aged 20-75 years, and adequate renal function. Cisplatin was administered with pre-hydration with 20 mEq of magnesium sulfate. Mannitol was administered just before cisplatin infusion to enforce diuresis. The primary endpoint was the proportion of patients who underwent cisplatin-based chemotherapy with a short hydration regimen with 20 mEq of magnesium supplementation without a grade 2 or higher elevation in creatinine., Results: Forty patients with a median age of 66 years (range 35-74) were prospectively enrolled. Median baseline creatinine was 0.71 mg/dL. Median dose of cisplatin in the first cycle was 80 mg/m2 . In the first cycle, no patients developed grade 2 creatinine toxicity. During the treatment period, one patient developed grade 2 creatinine elevation; thus, the proportion of patients without a grade 2 or higher elevation in creatinine was 97.5% (95% confidence interval 86.8-99.9)., Conclusion: A short hydration regimen with 20 mEq of magnesium supplementation is safe and feasible for patients with lung cancer receiving cisplatin-based chemotherapy.- Published
- 2020
- Full Text
- View/download PDF
28. Transcatheter arterial embolisation is efficient and safe for paediatric blunt torso trauma: a case-control study.
- Author
-
Gakumazawa M, Toida C, Muguruma T, Yogo N, Shinohara M, and Takeuchi I
- Subjects
- Adolescent, Adult, Case-Control Studies, Child, Female, Humans, Japan, Male, Middle Aged, Retrospective Studies, Trauma Centers, Embolization, Therapeutic methods, Hemorrhage therapy, Patient Safety, Thoracic Injuries therapy, Wounds, Nonpenetrating therapy
- Abstract
Background: It remains unclear whether transcatheter arterial embolisation (TAE) is as safe and effective for paediatric patients with blunt torso trauma as it is for adults in Japan, owing to few trauma cases and sporadic case reports. The study aimed to compare the efficacy and safety of TAE performed in paediatric (age ≤ 15 years) and adult patients with blunt torso trauma., Methods: This was a single-centre, retrospective chart review study that included blunt torso trauma patients who underwent TAE in the trauma centre from 2012 to 2017. The comparative study was carried out between a 'paediatric patient group' and an 'adult patient group'. The outcome measures for TAE were the success of haemorrhage control and complications and standardised mortality ratio (SMR)., Results: A total of 504 patients with blunt torso trauma were transported to the trauma centre, out of which 23% (N = 114) with blunt torso trauma underwent TAE, including 15 paediatric and 99 adult patients. There was no significant difference between the use of TAE in paediatric and adult patients with blunt torso trauma (29% vs 22%, P = .221). The paediatric patients' median age was 11 years (interquartile ranges 7-14). The predicted mortality rate and SMR for paediatric patients were lower than those for adult patients (18.3% vs 25.9%, P = .026, and 0.37 vs 0.54). The rate of effective haemorrhage control without repeated TAE or additional surgical intervention was 93% in paediatric patients, which was similar to that in adult patients (88%). There were no complications in paediatric patients at our centre. There were no significant differences in the proportion of paediatric patients who underwent surgery before TAE or urgent blood transfusion (33% vs 26%, P = .566, or 67% vs 85%, P = .084)., Conclusions: It is possible to provide an equal level of care related to TAE for paediatric and adult patients as it relates to TAE for blunt torso trauma with haemorrhage in the trauma centre. Alternative haemorrhage control procedures should be established as soon as possible whenever the patients reach a haemodynamically unstable state.
- Published
- 2020
- Full Text
- View/download PDF
29. Successful Management of Airway and Esophageal Foreign Body Obstruction in a Child.
- Author
-
Yogo N, Toida C, Muguruma T, Gakumazawa M, Shinohara M, and Takeuchi I
- Abstract
Foreign body asphyxia is a serious clinical problem with high morbidity and mortality rates. It is relatively common among children, especially those younger than 3 years, because they have a high risk of aspirating foreign bodies owing to their tendency to place objects in their mouth and lack of a well-developed swallowing reflex. Moreover, the neurologic outcome after out-of-hospital cardiac arrests (OHCA) in pediatric patients remains generally poor. Here, we report an unusual pediatric case of asphyxial OHCA caused by foreign bodies obstructing the airway, complicating esophageal foreign body, with a neurologically favorable outcome. This case highlights the importance of adequate treatment for pediatric patients with OHCA, as well as the prompt and efficient management for pediatric patients with foreign bodies obstructing the airway and esophagus., Competing Interests: The authors declare that there is no conflict of interest regarding the publication of this paper., (Copyright © 2019 Naoki Yogo et al.)
- Published
- 2019
- Full Text
- View/download PDF
30. Cardiopulmonary failure as a result of brainstem encephalitis caused by enterovirus D68.
- Author
-
Yogo N, Imamura T, Muto Y, and Hirai K
- Subjects
- Bulbar Palsy, Progressive therapy, Bulbar Palsy, Progressive virology, Child, Preschool, Female, Heart Failure therapy, Humans, Respiratory Insufficiency therapy, Brain Stem virology, Encephalitis, Viral complications, Enterovirus D, Human, Enterovirus Infections complications, Heart Failure virology, Respiratory Insufficiency virology
- Abstract
Enterovirus D68 (EV-D68) causes respiratory illnesses such as pneumonia, and has been reported to cause acute flaccid myelitis. Enterovirus A71 (EV-A71) is known to cause cardiopulmonary failure due to brainstem encephalitis, but there have been few reports of these conditions being associated with EV-D68. Outbreaks of EV-D68 infection have occurred in the USA, Canada, Europe and Asia. Clinical management is largely supportive and there are no specific antivirals available. The case patient, a 4-year-old girl, had cardiopulmonary failure due to brainstem encephalitis. EV-D68 was isolated from a throat swab. On admission, she had cardiopulmonary failure, which required intensive care using a ventilator and inotropic agents. Her cardiac function improved, but she had residual bulbar paralysis and limb weakness, which resolved over a 6-month period. This case confirms that EV-D68, may cause severe illness due to brainstem encephalitis, similar to that caused by EV-A71., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
31. TMS as a pharmacodynamic indicator of cortical activity of a novel anti-epileptic drug, XEN1101.
- Author
-
Premoli I, Rossini PG, Goldberg PY, Posadas K, Green L, Yogo N, Pimstone S, Abela E, Beatch GN, and Richardson MP
- Subjects
- Adult, Brain drug effects, Cross-Over Studies, Double-Blind Method, Electroencephalography, Evoked Potentials, Motor drug effects, Humans, Male, Transcranial Magnetic Stimulation, Anticonvulsants pharmacology, Cortical Excitability drug effects, Organic Chemicals pharmacology
- Abstract
Objective: Transcranial magnetic stimulation (TMS) produces characteristic deflections in the EEG signal named TMS-evoked EEG potentials (TEPs), which can be used to assess drug effects on cortical excitability. TMS can also be used to determine the resting motor threshold (RMT) for eliciting a minimal muscle response, as a biomarker of corticospinal excitability. XEN1101 is a novel potassium channel opener undergoing clinical development for treatment of epilepsy. We used TEPs and RMT to measure the effects of XEN1101 in the human brain, to provide evidence that XEN1101 alters cortical excitability at doses that might be used in future clinical trials., Methods: TMS measurements were incorporated in this Phase I clinical trial to evaluate the extent to which XEN1101 modulates TMS parameters of cortical and corticospinal excitability. TEPs and RMT were collected before and at 2-, 4-, and 6-hours post drug intake in a double-blind, placebo-controlled, randomized, two-period crossover study of 20 healthy male volunteers., Results: Consistent with previous TMS investigations of antiepileptic drugs (AEDs) targeting ion channels, the amplitude of TEPs occurring at early (15-55 msec after TMS) and at late (150-250 msec after TMS) latencies were significantly suppressed from baseline by 20 mg of XEN1101. Furthermore, the RMT showed a significant time-dependent increase that correlated with the XEN1101 plasma concentration., Interpretation: Changes from baseline in TMS measures provided evidence that 20 mg of XEN1101 suppressed cortical and corticospinal excitability, consistent with the effects of other AEDs. These results support the implementation of TMS as a tool to inform early-stage clinical trials., (© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.)
- Published
- 2019
- Full Text
- View/download PDF
32. Effects of establishing a trauma center on the mortality rate among injured pediatric patients in Japan.
- Author
-
Muguruma T, Toida C, Gakumazawa M, Yogo N, Shinohara M, and Takeuchi I
- Subjects
- Child, Child, Preschool, Female, Humans, Japan epidemiology, Male, Retrospective Studies, Wounds and Injuries epidemiology, Emergency Medical Services statistics & numerical data, Injury Severity Score, Transportation of Patients statistics & numerical data, Trauma Centers organization & administration, Wounds and Injuries mortality
- Abstract
Introduction: It remains unclear whether trauma centers are effective for the treatment of injured pediatric patients. The aim of this study was to evaluate children's mortality before and after the establishment a trauma center by using standard mortality ratios (SMR) and a modified observed-expected chart., Methods: This was a single center, retrospective chart review study that included injured pediatric patients (age <16 years) who were transported to our trauma center by the emergency medical services from 2012 to 2016 in Japan., Results: Our study included 143 subjects: 45 (31%) were preschoolers aged < 6 years, and 43 (30%) had an injury severity score (ISS) ≥ 16. After the trauma centers established, the number of patients increased (70% increase per month), as did the number of the patients with an ISS of 41-75. The percentage of indirect transportations was significantly higher in the trauma center than in the non-trauma center (49% vs. 28%; p < 0.05). The SMR was significantly lower in the trauma-center than in the non-trauma center (0.461 vs. 0.589; p < 0.05). The mean value of the modified observed-expected chart was significantly higher in the trauma-center than in the non-trauma center (4.6 vs. 2.3; p < 0.05). For the patients who were directly transferred to our center, the transfer distance was greater in the trauma-center than in the non-trauma center (6.8 vs. 6.2 km; p < 0.05). The time interval from hospital admission to initiation of computed tomography (15.5 vs. 33 minutes; p < 0.05) and to definitive care (44 vs. 64.5 minutes; p < 0.05) decreased in the after group compared to the non-trauma center., Conclusions: The results of our study revealed that the centralization of pediatric injured pediatric patients in trauma centers improved the mortality rate in this population in Japan., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
33. eIF2β, a subunit of translation-initiation factor EIF2, is a potential therapeutic target for non-small cell lung cancer.
- Author
-
Tanaka I, Sato M, Kato T, Goto D, Kakumu T, Miyazawa A, Yogo N, Hase T, Morise M, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV, Coombes KR, Kondo M, and Hasegawa Y
- Subjects
- A549 Cells, Adenocarcinoma drug therapy, Adenocarcinoma metabolism, Aged, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung metabolism, Cell Line, Cell Line, Tumor, Eukaryotic Initiation Factor-2 metabolism, Female, Humans, Kaplan-Meier Estimate, Lung Neoplasms drug therapy, Lung Neoplasms metabolism, Male, Middle Aged, Molecular Targeted Therapy, Protein Subunits genetics, Protein Subunits metabolism, RNA Interference, Adenocarcinoma genetics, Carcinoma, Non-Small-Cell Lung genetics, Eukaryotic Initiation Factor-2 genetics, Gene Expression Regulation, Neoplastic, Lung Neoplasms genetics
- Abstract
To identify novel therapeutic targets for non-small cell lung cancer (NSCLC), we conducted an integrative study in the following 3 stages: (i) identification of potential target gene(s) through shRNA functional screens in 2 independent NSCLC cell lines; (ii) validation of the clinical relevance of identified gene(s) using public databases; and (iii) investigation of therapeutic potential of targeting the identified gene(s) in vitro. A semi-genome-wide shRNA screen was performed in NCI-H358 cells, and was integrated with data from our previous screen in NCI-H460 cells. Among genes identified in shRNA screens, 24 were present in both NCI-H358 and NCI-H460 cells and were considered potential targets. Among the genes, we focused on eIF2β, which is a subunit of heterotrimeric G protein EIF2 and functions as a transcription initiation factor. The eIF2β protein is highly expressed in lung cancer cell lines compared with normal bronchial epithelial cells, and gene copy number analyses revealed that eIF2β is amplified in a subset of NSCLC cell lines. Gene expression analysis using The Cancer Genome Atlas (TCGA) dataset revealed that eIF2β expression is significantly upregulated in lung cancer tissues compared with corresponding normal lung tissues. Furthermore, high eIF2β expression was correlated with poor survival in patients with lung adenocarcinoma, as shown in other cohorts using publicly available online tools. RNAi-mediated depletion of eIF2β suppresses growth of lung cancer cells independently of p53 mutation status, in part through G1 cell cycle arrest. Our data suggest that eIF2β is a therapeutic target for lung cancer., (© 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Published
- 2018
- Full Text
- View/download PDF
34. Introduction of Pediatric Physiological and Anatomical Triage Score in Mass-Casualty Incident.
- Author
-
Toida C, Muguruma T, Abe T, Shinohara M, Gakumazawa M, Yogo N, Shirasawa A, and Morimura N
- Subjects
- Adolescent, Child, Child, Preschool, Emergency Service, Hospital, Humans, Infant, Intensive Care Units, Japan, ROC Curve, Retrospective Studies, Sensitivity and Specificity, Child, Hospitalized, Injury Severity Score, Mass Casualty Incidents mortality, Patient Admission, Pediatrics, Triage
- Abstract
Background: Triage has an important role in providing suitable care to the largest number of casualties in a disaster setting, but there are no secondary triage methods suitable for children. This study developed a new secondary triage method named the Pediatric Physiological and Anatomical Triage Score (PPATS) and compared its accuracy with current triage methods., Methods: A retrospective chart review of pediatric patients under 16 years old transferred to an emergency center from 2014 to 2016 was performed. The PPATS categorized the patients, defined the intensive care unit (ICU)-indicated patients if the category was highest, and compared the accuracy of prediction of ICU-indicated patients among PPATS, Physiological and Anatomical Triage (PAT), and Triage Revised Trauma Score (TRTS)., Results: Among 137 patients, 24 (17.5%) were admitted to ICU. The median PPATS score of these patients was significantly higher than that of patients not admitted to ICU (11 [IQR: 9-13] versus three [IQR: 2-4]; P<.001). The optimal cut-off value of the PPTAS was six, yielding a sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 95.8%, 86.7%, 60.5%, and 99.0%. The area under the receiver-operating characteristic curve (AUC) was larger for PPTAS than for PAT or TRTS (0.95 [95% CI, 0.87-1.00] versus 0.65 [95% CI, 0.58-0.72]; P<.001 and 0.79 [95% CI, 0.69-0.89]; P=.003, respectively). Regression analysis showed a significant association between the PPATS and the predicted mortality rate (r2=0.139; P<.001), ventilation time (r2=0.320; P<.001), ICU stay (r2=0.362; P<.001), and hospital stay (r2=0.308; P<.001)., Conclusions: The accuracy of PPATS was superior to other methods for secondary triage of children. Toida C , Muguruma T , Abe T , Shinohara M , Gakumazawa M , Yogo N , Shirasawa A , Morimura N . Introduction of pediatric physiological and anatomical triage score in mass-casualty incident. Prehosp Disaster Med. 2018;33(2):147-152.
- Published
- 2018
- Full Text
- View/download PDF
35. Intervention to Reduce Broad-Spectrum Antibiotics and Treatment Durations Prescribed at the Time of Hospital Discharge: A Novel Stewardship Approach.
- Author
-
Yogo N, Shihadeh K, Young H, Calcaterra SL, Knepper BC, Burman WJ, Mehler PS, and Jenkins TC
- Subjects
- Academic Medical Centers, Colorado, Databases, Factual, Hospitalization, Humans, Medical Audit, Medical Records, Patient Discharge, Pharmacists, Program Evaluation, Retrospective Studies, Anti-Bacterial Agents therapeutic use, Drug Utilization statistics & numerical data, Gram-Negative Bacterial Infections drug therapy, Inappropriate Prescribing statistics & numerical data
- Abstract
OBJECTIVE For most common infections requiring hospitalization, antibiotic treatment is completed after hospital discharge. Postdischarge therapy is often unnecessarily broad spectrum and prolonged. We developed an intervention to improve antibiotic selection and shorten treatment durations. DESIGN Single center, quasi-experimental retrospective cohort study METHODS Patients prescribed oral antibiotics at hospital discharge before (July 2012-June 2013) and after (October 2014-February 2015) an intervention consisting of (1) institutional guidance for oral step-down antibiotic selection and duration of therapy and (2) pharmacy audit of discharge prescriptions with real-time prescribing recommendations to providers. The primary outcomes measured were total prescribed duration of therapy and use of antibiotics with broad gram-negative activity (ie, fluoroquinolones or amoxicillin-clavulanate). RESULTS Overall, 300 cases from the preintervention period and 200 cases from the intervention period were included. Compared with the preintervention period, the use of antibiotics with broad gram-negative activity decreased during the intervention (51% vs 40%; P=.02), particularly fluoroquinolones (38% vs 25%; P=.002). The total duration of therapy decreased from a median of 10 days (interquartile range [IQR], 7-13 days) to 9 days (IQR, 6-13 days) but did not reach statistical significance (P=.13). However, the duration prescribed at discharge declined from 6 days (IQR, 4-10 days) to 5 days (IQR, 3-7 days) (P=.003). During the intervention, there was a nonsignificant increase in the overall appropriateness of discharge prescriptions from 52% to 66% (P=.15). CONCLUSIONS A multifaceted intervention to optimize antibiotic prescribing at hospital discharge was associated with less frequent use of antibiotics with broad gram-negative activity and shorter postdischarge treatment durations. Infect Control Hosp Epidemiol 2017;38:534-541.
- Published
- 2017
- Full Text
- View/download PDF
36. Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer.
- Author
-
Kakumu T, Sato M, Goto D, Kato T, Yogo N, Hase T, Morise M, Fukui T, Yokoi K, Sekido Y, Girard L, Minna JD, Byers LA, Heymach JV, Coombes KR, Kondo M, and Hasegawa Y
- Subjects
- A549 Cells, Aged, Apoptosis genetics, Blotting, Western, Carcinoma, Non-Small-Cell Lung metabolism, Carcinoma, Non-Small-Cell Lung pathology, Cell Line, Cell Line, Tumor, Cell Proliferation genetics, Cell Survival genetics, Female, G2 Phase Cell Cycle Checkpoints genetics, Gene Amplification, Gene Expression Profiling methods, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Lung Neoplasms metabolism, Lung Neoplasms pathology, Male, Molecular Targeted Therapy, Proteasome Endopeptidase Complex metabolism, RNA Interference, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction genetics, Carcinoma, Non-Small-Cell Lung genetics, Catalytic Domain genetics, Gene Expression Regulation, Neoplastic, Lung Neoplasms genetics, Proteasome Endopeptidase Complex genetics
- Abstract
To identify potential therapeutic targets for lung cancer, we performed semi-genome-wide shRNA screening combined with the utilization of genome-wide expression and copy number data. shRNA screening targeting 5043 genes in NCI-H460 identified 51 genes as candidates. Pathway analysis revealed that the 51 genes were enriched for the five pathways, including ribosome, proteasome, RNA polymerase, pyrimidine metabolism and spliceosome pathways. We focused on the proteasome pathway that involved six candidate genes because its activation has been demonstrated in diverse human malignancies, including lung cancer. Microarray expression and array CGH data showed that PSMA6, a proteasomal subunit of a 20S catalytic core complex, was highly expressed in lung cancer cell lines, with recurrent gene amplifications in some cases. Therefore, we further examined the roles of PSMA6 in lung cancer. Silencing of PSMA6 induced apoptosis or G2/M cell cycle arrest in cancer cell lines but not in an immortalized normal lung cell line. These results suggested that PSMA6 serves as an attractive target with a high therapeutic index for lung cancer., (© 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Published
- 2017
- Full Text
- View/download PDF
37. Clinical Characteristics, Diagnostic Evaluation, and Antibiotic Prescribing Patterns for Skin Infections in Nursing Homes.
- Author
-
Yogo N, Gahm G, Knepper BC, Burman WJ, Mehler PS, and Jenkins TC
- Abstract
Background: The epidemiology and management of skin infections in nursing homes has not been adequately described. We reviewed the characteristics, diagnosis, and treatment of skin infections among residents of nursing homes to identify opportunities to improve antibiotic use., Methods: This was a retrospective study involving 12 nursing homes in the Denver metropolitan area. For residents at participating nursing homes diagnosed with a skin infection between July 1, 2013 and June 30, 2014, clinical and demographic information was collected through manual chart review., Results: Of 100 cases included in the study, the most common infections were non-purulent cellulitis (n = 55), wound infection (n = 27), infected ulcer (n = 8), and cutaneous abscess (n = 7). In 26 cases, previously published minimum clinical criteria for initiating antibiotics (Loeb criteria) were not met. Most antibiotics (n = 52) were initiated as a telephone order following a call from a nurse, and 41 patients were not evaluated by a provider within 48 h after initiation of antibiotics. Nearly all patients (n = 95) were treated with oral antibiotics alone. The median treatment duration was 7 days (interquartile range 7-10); 43 patients received treatment courses of ≥10 days., Conclusion: Most newly diagnosed skin infections in nursing homes were non-purulent infections treated with oral antibiotics. Antibiotics were initiated by telephone in over half of cases, and lack of a clinical evaluation within 48 h after starting antibiotics was common. Improved diagnosis through more timely clinical evaluations and decreasing length of therapy are important opportunities for antibiotic stewardship in nursing homes.
- Published
- 2016
- Full Text
- View/download PDF
38. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship.
- Author
-
Yogo N, Haas MK, Knepper BC, Burman WJ, Mehler PS, and Jenkins TC
- Subjects
- Community-Acquired Infections drug therapy, Drug Utilization Review, Female, Humans, Inappropriate Prescribing statistics & numerical data, Male, Middle Aged, Pneumonia, Bacterial drug therapy, Retrospective Studies, Skin Diseases, Bacterial drug therapy, Urinary Tract Infections drug therapy, Anti-Bacterial Agents therapeutic use, Drug Prescriptions statistics & numerical data, Hospitalization statistics & numerical data, Patient Discharge statistics & numerical data
- Abstract
Of 300 patients prescribed oral antibiotics at the time of hospital discharge, urinary tract infection, community-acquired pneumonia, and skin infections accounted for 181 of the treatment indications (60%). Half of the prescriptions were antibiotics with broad Gram-negative activity. Discharge prescriptions were inappropriate in 79 of 150 cases reviewed (53%).
- Published
- 2015
- Full Text
- View/download PDF
39. Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells.
- Author
-
Yamashita R, Sato M, Kakumu T, Hase T, Yogo N, Maruyama E, Sekido Y, Kondo M, and Hasegawa Y
- Subjects
- Antineoplastic Agents pharmacology, Apoptosis genetics, Carcinoma, Non-Small-Cell Lung pathology, Cell Division drug effects, Cell Line, Tumor, Epithelial-Mesenchymal Transition genetics, Humans, Lung Neoplasms pathology, Real-Time Polymerase Chain Reaction, S Phase drug effects, Carcinoma, Non-Small-Cell Lung genetics, Lung Neoplasms genetics, MicroRNAs physiology
- Abstract
Both pro- and anti-oncogenic roles of miR-221 and miR-222 microRNAs are reported in several types of human cancers. A previous study suggested their oncogenic role in invasiveness in lung cancer, albeit only one cell line (H460) was used. To further evaluate involvement of miR-221 and miR-222 in lung cancer, we investigated the effects of miR-221 and miR-222 overexpression on six lung cancer cell lines, including H460, as well as one immortalized normal human bronchial epithelial cell line, HBEC4. miR-221 and miR-222 induced epithelial-to-mesenchymal transition (EMT)-like changes in a minority of HBEC4 cells but, unexpectedly, both the microRNAs rather suppressed their invasiveness. Consistent with the prior report, miR-221 and miR-222 promoted growth in H460; however, miR-221 suppressed growth in four other cell lines with no effects in one, and miR-222 suppressed growth in three cell lines but promoted growth in two. These are the first results to show tumor-suppressive effects of miR-221 and miR-222 in lung cancer cells, and we focused on clarifying the mechanisms. Cell cycle and apoptosis analyses revealed that growth suppression by miR-221 and miR-222 occurred through intra-S-phase arrest and/or apoptosis. Finally, lung cancer cell lines transfected with miR-221 or miR-222 became more sensitive to the S-phase targeting drugs, possibly due to an increased S-phase population. In conclusion, our data are the first to show tumor-suppressive effects of miR-221 and miR-222 on lung cancer, warranting testing their potential as therapeutics for the disease., (© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
40. Syphilis presenting as retinal detachment and orchitis in a young man with HIV.
- Author
-
Yogo N, Nichol AC, Campbell TB, and Erlandson KM
- Subjects
- Adult, Coinfection, Follow-Up Studies, HIV Infections drug therapy, Humans, Male, Ophthalmoscopy, Syphilis complications, Syphilis drug therapy, Treatment Outcome, Visual Acuity, Anti-Bacterial Agents therapeutic use, HIV Infections complications, Orchitis microbiology, Penicillin G therapeutic use, Retinal Detachment microbiology, Syphilis diagnosis
- Abstract
Retinal detachment and testicular lesions are 2 rare presentations of syphilis. We describe a man with bilateral retinal detachment from ocular syphilis and syphilitic orchitis as a manifestation of syphilis and HIV coinfection.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.